patent.fyi
Applications  /  US 2026/0355176
United States Patent Application Publication

US 2026/0355176 A1

Published
Nov 12, 2026
Filed
Jul 21, 2026
Earliest date on the face
Sep 11, 2019
Classification
A61K 31/465
First published here
Nov 19, 2026

Generated automatically. Not reviewed by a person. Not legal advice or an opinion.

Section 1 · machine-generated

What if?

Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.

1.1Metered liquid reservoir

What ifWhat if a metered pump dispensed the oral composition as a liquid with no filler?
Claim language“at least one filler”

Water serves as the solvent for the dissolved ingredients in a sealed reservoir. A fixed-volume pump chamber delivers a measured portion into the mouth with each actuation.

1.2Menthol oral active

What ifWhat if the composition delivered menthol as its oral active and contained no basic amine?
Claim language“a basic amine”

A cyclodextrin inclusion complex carries menthol in the oral matrix. Saliva dissolves the cyclodextrin, and released menthol activates cold-sensitive receptors in the mouth.

1.4Inorganic phosphate buffer

What ifWhat if inorganic phosphate salts controlled amine protonation with no organic acid or organic acid salt in the composition?
Claim language“an organic acid, an alkali metal salt of an organic acid”

Sodium dihydrogen phosphate and disodium hydrogen phosphate dissolve in the aqueous phase. Their ratio sets the pH, which controls the fraction of the amine present in protonated form.

1.5Citric acid below the range

What ifWhat if the organic acid was citric acid, with a log P below 1.4?
Claim language“a log P value of from about 1.4 to about 8.0”

Citric acid dissolves in the water phase and transfers protons to the basic amine. The citric acid-to-amine ratio controls the formulation pH and the fraction of protonated amine.

1.6Diffusion through a polymer coating

What ifWhat if a neutral polymer coating controlled release of the free-base amine without an organic acid salt or ion pair?
Claim language“a basic amine-organic acid salt, an ion pair”

A dry porous cellulose core holds the free-base amine beneath an ethylcellulose coating that contains a water-soluble pore former. Saliva dissolves the pore former, and the amine diffuses through the resulting channels.

Section 2 · machine-generated

Variations

Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.

Other field of use

Flow cell for saliva release testing

A laboratory flow cell holds a hydrated filler containing nicotine and an organic acid behind a porous screen. A pump delivers artificial saliva across the exposed face of the formulation at a constant flow rate. Timed samples from the outlet provide a release profile for total nicotine and the acid.

Component substitution

Calcium phosphate filler in a pouch

Granulated dibasic calcium phosphate replaces a fibrous cellulose filler in a porous oral pouch. An aqueous mixture of nicotine and the organic acid wets the granules before pouch filling. Water retained between the granules provides a liquid phase for association between protonated nicotine and the organic acid anion.

Parameter or scale variation

Two granule sizes at fixed composition

Dry cellulose filler is sieved into 150–300 micrometer and 600–850 micrometer fractions. Each fraction receives the same mass of an aqueous nicotine and organic acid mixture per gram of dry filler and is packed into the same pouch geometry. The two particle sizes produce different interparticle void geometries that affect saliva penetration into the pouch.

Combination with existing systems

Mucoadhesive film with a hydrated layer

A laminated buccal film carries a thin hydrated layer of cellulose filler, nicotine, and organic acid on its mucosa-facing side. A hydroxypropyl methylcellulose film forms a mucoadhesive border around the hydrated layer, and a water-resistant ethylcellulose film backs the assembly. Saliva hydrates the border, and the backing limits washout from the outward face.

Rupturable water reservoir for oral pouches

A two-compartment wrapper holds an oral pouch containing dry filler and a dried nicotine–organic acid salt in one compartment and a measured charge of water in the other. Pressure on the water compartment opens a frangible seal and transfers the water to the pouch inside the closed wrapper. The filler takes up the water, and the salt dissolves into the liquid retained between filler particles before the pouch is removed.

Automated or data-driven variant

Automated wet blending with ph feedback

A controller meters filler, water, nicotine solution, and organic acid solution into a jacketed mixer using load cell readings. A sampling probe transfers a portion of the blend to a measurement cup, where a fixed water-to-sample ratio is used for pH measurement. The controller adds small increments of organic acid solution to bring the measured pH into a preset batch window and records the amount added.

Specific version of a part

Microcrystalline cellulose filler

Microcrystalline cellulose provides bulk in the oral composition. The fibrous particles absorb and distribute the aqueous phase through the mixture.

Nicotine in the aqueous phase

Nicotine is dispersed in the aqueous phase during mixing. The formulation pH governs the distribution between uncharged nicotine and its protonated forms.

Benzoic acid partition coefficient

Benzoic acid supplies the organic acid component. Its uncharged form has an octanol-to-water log P of approximately 1.9.

Nicotine benzoate salt formation

Benzoic acid transfers a proton to the pyrrolidine nitrogen of nicotine. Protonated nicotine and benzoate are the charged constituents of the resulting salt.

Section 3 · quoted from USPTO records

Other work

Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.

Document AUS 2015/0246007 A1
Published
Sep 3, 2015
Filed
May 18, 2015
Class
A61K 9/7061
Document BUS 9,943,511 B2
Published
Apr 17, 2018
Filed
Apr 29, 2016
Class
A61K 31/465
Claim 1
Document A
Document B
1.1at least one filler;
As indicated in the above, in some embodiments, the reservoir or the adhesive may contain additional components such as, additives, permeation enhancers, stabilizers, dyes, diluents, plasticizer, tackifying agent, pigments, carriers, inert fillers, antioxidants, excipients, gelling agents, anti-irritants, vasoconstrictors and other materials as are generally known to the transdermal art.
A · US 2015/0246007 A1 · ¶ 65
1.2a basic amine;
Nicotine, a basic drug with two pKa of about 8 and 3, respectively, is expected to be more irritating when delivered as the base than when delivered as a salt.
A · US 2015/0246007 A1 · ¶ 30
Nicotine, or 3-(1-methyl-2-pyrrolidinyl) pyridine, is a tertiary amine with the following structure:
B · US 9,943,511 B2 · ¶ 5
1.3water; and
In some cases, water content in a nicotine lozenge provided herein ranges from 2 weight percent to 15 weight percent.
B · US 9,943,511 B2 · ¶ 76
1.4an organic acid, an alkali metal salt of an organic acid, or a combination thereof;
An excess of acid including, but not limited to, e.g., organic and carboxylic acids, such as, acetic acid, propionic acid, butyric acid, citric acid, succinic acid, glycolic acid, gluconic acid, glucuronic acid, hexanoic acid, pentanoic acid, heptanoic acid, levulinic acid, lactic acid, malic acid, pyruvic acid, tartaric acid, tartronic acid, or fumaric acid, is added to the formulation in order to control pH.
A · US 2015/0246007 A1 · ¶ 35
Suitable examples of antioxidants include ascorbyl palmitate (a vitamin C ester), BHT, ascorbic acid (Vitamin C), and sodium ascorbate (Vitamin C salt).
B · US 9,943,511 B2 · ¶ 59
1.5wherein the organic acid has a log P value of from about 1.4 to about 8.0, and
1.6at least a portion of the basic amine is associated with at least a portion of the organic acid or the alkali metal salt thereof, the association in the form of a basic amine-organic acid salt, an ion pair between the basic amine and a conjugate base of the organic acid, or both.
Examples of such acids include acetic acid, propionic acid, butyric acid, citric acid, succinic acid, glycolic acid, gluconic acid, glucuronic acid, lactic acid, malic acid, pyruvic acid, tartaric acid, tartronic acid, and fumaric acid. The corresponding salts to the acids will be acetate, propionate, butyrate, citrate, succinate, etc.
A · US 2015/0246007 A1 · ¶ 32
A nicotine lozenge, comprising a body that is wholly receivable in an oral cavity, the body comprising: a digestion-resistant maltodextrin matrix; nicotine or a nicotine derivative dispersed in the digestion-resistant maltodextrin matrix such that the nicotine or derivative thereof is released from the body as the body dissolves when the body is at least partially received within the oral cavity of an adult tobacco consumer and exposed to saliva, the nicotine or the nicotine
B · US 9,943,511 B2 · claim 26

An empty cell means only that no passage was reproduced there.

Statements in these documents
In particular, the invention relates to transdermal systems for administration of nicotine salt with adhesive system having high drug and enhancer tolerance when used in transdermal drug delivery.
A · US 2015/0246007 A1 · ¶ 2
Such a need is especially keen for drugs such as nicotine salt, which is hard to deliver in doses high enough for therapy for some ailments.
A · US 2015/0246007 A1 · ¶ 7
Chemical and physical properties of nicotine present a number of processing and stability issues.
B · US 9,943,511 B2 · ¶ 7
A nicotine lozenge provided herein provides a satisfying tactile and/or flavor experience.
B · US 9,943,511 B2 · ¶ 8
Cite aspatent.fyi, US 2026/0355176 A1, claim 1, first published 2026-11-19T09:07:06-05:00, https://patent.fyi/US20260355176/, SHA-256 c8342b65ffdd2b3d8a237c5997be2b37e7429526a8593e5afdfdb0746e793323
First published
Permanent addresshttps://patent.fyi/US20260355176/
Content fingerprint (SHA-256)c8342b65ffdd2b3d8a237c5997be2b37e7429526a8593e5afdfdb0746e793323
Methodv2026-11-18.2 · automated, not reviewed by a person
Correctionscorrections@patent.fyi